OSAKA - Kobayashi Pharmaceutical Co. said Friday it is looking into 76 more deaths linked to the consumption of its red yeast rice dietary supplements, with the government upset by how slow the company has been in releasing information since the first suspected death reported in March.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
